Suchergebnisse - "BNT162 vaccine"

PubPharm (3.928)

71

Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus

enthalten in: JCI insight | 2024

von Sarin, K. | Zheng, H. | Chaichian, Y. | +19

72

Reactogenicity and Peak Anti-RBD-S1 IgG Concentrations in Individuals with No Prior COVID-19 Infection Vaccinated with Different SARS-CoV-2 Vaccines

enthalten in: Laboratory medicine | 2024

von Milevoj Kopcinovic, L. | Unic, A. | Nikolac Gabaj, N. | +4

73

25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations

enthalten in: Vaccine | 2024

von Lavell, A. | Schramade, A. | Sikkens, J. | +35

74

SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose : Homologous versus heterologous boost

enthalten in: Vaccine | 2024

von Lijeskić, O. | Bauman, N. | Marković, M. | +4

75

Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults : A population-based observational study

enthalten in: Vaccine | 2024

von Kim, H. | Park, S. | Choe, S. | +10

76

Mortality risk after COVID-19 vaccination : A self-controlled case series study

enthalten in: Vaccine | 2024

von Xu, S. | Sy, L. | Hong, V. | +16

77

Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand : Retrospective Cohort Study Using National Registration Data

enthalten in: JMIR public health and surveillance | 2024

von Kumwichar, P. | Poonsiri, C. | Botwright, S. | +7

78

Strong humoral response after Covid-19 vaccination correlates with the common HLA allele A*03:01 and protection from breakthrough infection

enthalten in: HLA | 2024

von Crocchiolo, R. | Frassati, C. | Gallina, A. | +10

79

Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B and BNT162b2 in a phase 2 randomized, observer-blinded study

enthalten in: Scientific reports | 2024

von Reiter, L. | Greffrath, J. | Zidel, B. | +8

80

Evaluation of the hematological and immunological markers after the first and second doses of BNT162b2 mRNA vaccine

enthalten in: European review for medical and pharmacological sciences | 2024

von Rafeeq, M. | Jabir, M. | Al-Kuraishy, H. | +9